Overview

Safety and Efficacy Trial of Testosterone Undecanoate

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if oral testosterone undecanoate is effective and safe in the treatment of low testosterone in men.
Phase:
Phase 3
Details
Lead Sponsor:
Clarus Therapeutics, Inc.
Collaborator:
inVentiv Health Clinical
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate